Skip to Main Content
Try STAT+ TODAY
Trending:
Health
Biotech
The Obesity Revolution
STAT+
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
Biotech
STAT+

A venture firm warms to funding neuroscience

  • Matthew Herper

By Matthew Herper Jan. 16, 2020

Reprints
Brain neurons
Adobe

Longtime venture capital star Beth Seidenberg and former Amgen R&D chief Sean Harper say they have funded 10 companies from their new fund, Westlake Village BioPartners. But only three — the cell therapy companies Kyverna, Tmunity, and Arsenal Biosciences — are publicly known.

Any hints?

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

About the Author Reprints

Matthew Herper

Matthew Herper

Senior Writer, Medicine, Editorial Director of Events

Matthew Herper covers medical innovation — both its promise and its perils.

Tags

There is no epidemic of autism. It’s an epidemic…
There is no epidemic of autism. It’s an epidemic of need
Why fentanyl is deadlier than heroin, in a single…
Why fentanyl is deadlier than heroin, in a single photo
Up and down the ladder: The latest comings and…
Up and down the ladder: The latest comings and goings
Pharmalittle: EU delays pharma legislation again; India cancels license…
Pharmalittle: EU delays pharma legislation again; India cancels license for maker of cough syrup linked to…
The surprising biomedical legacy of the Iraq War
The surprising biomedical legacy of the Iraq War
J&J loses a patent battle in India over a…
J&J loses a patent battle in India over a crucial tuberculosis drug

Recommended Stories